Ikei S. Kobayashi

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors”.

EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100051

N/A

0DataRank · unranked

81 citations

Carol Gergis, Hollis Viray, Andreas Varkaris, Masanori Fujii, Deepa Rangachari +5 more

Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100105

N/A

0DataRank · unranked

23 citations

Ikei S. Kobayashi, Susumu Kobayashi, Daniel B. Costa, Pedro Eduardo Nascimento Silva Vasconcelos

Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutator

International Journal of Hematology(2020)10.1007/s12185-020-02904-y

N/A

0DataRank · unranked

7 citations

Hirofumi Fukuda, Gilbert Pan, Hiroyuki Yamazaki, Tadahiko Matsumoto, Yasuhiro Kazuma +9 more

Preclinical characterization of mobocertinib highlights the putative therapeutic window of this novel EGFR inhibitor to EGFR exon 20 insertion mutations

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.28.317560

N/A

0DataRank · unranked

20 citations

Ikei S. Kobayashi, Susumu Kobayashi, Daniel B. Costa, Pedro Eduardo Nascimento Silva Vasconcelos

Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Cancer Research(2021)10.1158/0008-5472.can-20-2811

N/A

0DataRank · unranked

104 citations

Daisuke Shibahara, Ayako Suzuki, Kyoko Muto, Ikei S. Kobayashi, David Plotnick +12 more

NAD Modulates DNA Methylation and Cell Differentiation

Cells(2021)10.3390/cells10112986

N/A

0DataRank · unranked

26 citations

Clinton Hausman, Giulia Gaggi, Lucrezia Rinaldi, Mahmoud A. Bassal, Yanzhou Zhang +9 more

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms

Cancer Science(2021)10.1111/cas.15210

N/A

0DataRank · unranked

6 citations

Juan Luiz Coelho‐Silva, Cristina Tavares Leal, Adriana Queiroz Arantes Rocha, Thiago Mantello Bianco, Robert S. Welner +8 more

TIP60 is required for tumorigenesis in non‐small cell lung cancer

Cancer Science(2023)10.1111/cas.15785

N/A

0DataRank · unranked

19 citations

Naoki Akanuma, Ikei S. Kobayashi, Eunyoung Heo, Mariko Ando, Masanori Fujii +10 more

The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100614

N/A

0DataRank · unranked

11 citations

William O. Shaffer, Hollis Viray, Deepa Rangachari, Paul A. VanderLaan, Susumu Kobayashi +2 more

EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors

Lung Cancer(2023)10.1016/j.lungcan.2023.107250

N/A

0DataRank · unranked

6 citations

Ikei S. Kobayashi, Daniel Sentana‐Lledo, Shriram K. Sundararaman, Meghan Lee, Deepa Rangachari +4 more

Data from Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

(2023)10.1158/0008-5472.c.6512902.v1

N/A

0DataRank · unranked

0 citations

Daisuke Shibahara, Ayako Suzuki, Kyoko Muto, Ikei S. Kobayashi, David Plotnick +12 more

Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer

Cell Death and Disease(2024)10.1038/s41419-024-06940-y

N/A

0DataRank · unranked

18 citations

Masanori Fujii, Ikei S. Kobayashi, Vivian Ho, Yukie Kashima, Hibiki Udagawa +3 more

Efficacy of EGFR tyrosine kinase inhibitors in patients with non–small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)

Lung Cancer(2025)10.1016/j.lungcan.2025.108479

N/A

0DataRank · unranked

0 citations

Hiroki Izumi, Ikei S. Kobayashi, Shingo Matsumoto, Yukio Hosomi, Takae Okuno +23 more